Role of EZH2 in cancer stem cells: from biological insight to a therapeutic target

Epigenetic modifications in cancer stem cells largely result in phenotypic and functional heterogeneity in many solid tumors. Increasing evidence indicates that enhancer of zeste homolog 2 (EZH2), the catalytic subunit of Polycomb repressor complex 2, is highly expressed in cancer stem cells of nume...

Descripción completa

Detalles Bibliográficos
Autores principales: Wen, Yiping, Cai, Jing, Hou, Yaya, Huang, Zaiju, Wang, Zehua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5514966/
https://www.ncbi.nlm.nih.gov/pubmed/28415635
http://dx.doi.org/10.18632/oncotarget.16467

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5514966/
https://www.ncbi.nlm.nih.gov/pubmed/28415635
http://dx.doi.org/10.18632/oncotarget.16467

Ejemplares similares